Koning Corporation, a leading developer of advanced medical imaging systems which combine the advantages of Digital X-ray and Computed Tomography called Cone Beam Computed Tomography (CBCT) announced today that they have obtained the Canadian Medical Device License from Health Canada for their Koning Breast CT (KBCT) system and Biopsy Bracket add-on option that enables KBCT-Guided Biopsy.

As the wait continues for improved breast screening methods, better understanding of associated harms, enhanced strategies for identification of high-risk patients, and tools to assist patients and clinicians in incorporating these factors into their decisions should be research priorities, according to a review published on April 2 by the Journal of the American Medical Association. 

Nonenhanced MRI has demonstrated high diagnostic performance that is similar to that of ultrasound for suspected pediatric appendicitis, according to a study published online March 17 by Radiology. 

A history of breast conservation therapy (BCT) in patients could be a reasonable indication for single-screening breast MRI in women younger than 50, according to a study published online Mar. 17 by Radiology. 

Emergency department bedside ultrasonography demonstrated better sensitivity as stone size and number increased in a population of patients with CT-proven urinary stones, according to a study published in volume 15 of the Western Journal of Emergency Medicine

Researchers have identified MRI features at 24 hours post-cryoablation that were predictive of local liver tumor progression, according to a study published by the American Journal of Roentgenology. These include a minimum ablation margin less than or equal to three millimeters and a blood vessel bridging the margin. 

Patients with carpal tunnel syndrome (CTS) differ from normal subjects in terms of mobility and deformability of the median nerve, according to a study published in the April issue of Academic Radiology.

Higher follow-on diagnostic rates, variation in patterns of follow-on diagnostics, higher breast biopsy rates, and higher false positive biopsy rates due to Affordable Care Act (ACA) provisions demonstrate the need for payer and employer evaluation of the quality and value of breast cancer screening follow-on diagnostic patterns, according to an actuarial analysis published by Milliman on Feb. 20.